RxSight, Inc.
corporate_fare Company Profile
RxSight, Inc. (NASDAQ:RXST) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 15 items for RXST at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-03, rated 7/10. Across its 15 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for RXST spans 10-Q, 8-K, SC TO-I, 10-K.
Recent high-impact activity:
- RxSight 10-Q: Q3 Revenue Down 19% to $24.6M, $254.7M Cash, Alcon $50M Now Nonrefundable
- RxSight Q3 Revenue Falls 19% to $24.6M; Net Loss Widens to $16.2M
- Q3 Revenue Falls 19% to $24.6M as Net Loss Widens to $16.2M
- RxSight Launches Option Exchange to Retain Talent Amid Stock Slump
- RxSight Taps Aziz Mottiwala as CEO, Succeeding Founder Ron Kurtz; New Chief Lands $14M Equity Grant
Financial Snapshot
Short Interest & Short Volume
6.07 days to coverFINRA reported short interest of 3,633,588 shares in RXST as of the October 30, 2026 settlement, a 11.8% decrease from the prior period — about 6.1 days to cover at its recent average daily volume. On November 20, 2026, 52.1% of RXST volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.